Fora Capital, LLC Madrigal Pharmaceuticals, Inc. Transaction History

Fora Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$58.39 - $296.54 $283,249 - $1.44 Million	4,851 New	4,851 $1.41 Million
Q3 2021 Nov 15, 2021	SELL	$78.35 - $105.02 $42,544 - $57,025	-543 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$97.2 - $137.59 $52,779 - $74,711	543 New	543 $53 Million
Q1 2021 May 17, 2021	SELL	$108.54 - $125.2 $111,362 - $128,455	-1,026 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$110.06 - $133.7 $112,921 - $137,176	1,026 New	1,026 $114,000
Q3 2020 Nov 13, 2020	SELL	$99.78 - $124.21 $127,917 - $159,237	-1,282 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$60.13 - $125.71 $77,086 - $161,160	1,282 New	1,282 $145 Million

296

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.94B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.